Ofuna Technology Co., Ltd. (4577)
TWSE 
JPX Primary TWSE Summary
4577 Chart
Ofuna Technology Co., Ltd. (4577) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Ofuna Technology Co., Ltd. ever had a stock split?
Ofuna Technology Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Hiroshi Matsumori CEO | TWSE Exchange | TW0004577002 ISIN |
| Japan Country | 1,073 Employees | 28 May 2026 Last Dividend | 29 May 2025 Last Split | - IPO Date |
Overview
Daito Pharmaceutical Co.,Ltd. is a distinguished entity in the global pharmaceutical industry, specializing in the manufacture and sale of a diverse range of pharmaceutical products. The company's origins trace back to 1942, initially established under the name Daito Corporation before evolving into Daito Pharmaceutical Co.,Ltd. in 1992. Through decades of innovation and service, it has cemented its presence worldwide, operating from its headquarters in Toyama, Japan. The company's trajectory over the years underscores a commitment to excellence, innovation, and the provision of high-quality pharmaceutical solutions to meet the health needs of people globally.
Products and Services
Daito Pharmaceutical Co.,Ltd. offers a comprehensive portfolio of products and services designed to meet a wide array of healthcare needs. These include:
- Generic Drugs: The company specializes in the development and distribution of generic drugs, which serve as affordable alternatives to name-brand prescription medicines, without compromising on quality or efficacy.
- Active Pharmaceutical Ingredients (APIs): Daito Pharmaceutical is a key supplier of active pharmaceutical ingredients, crucial components in the production of a myriad of drugs. These APIs are provided to other pharmaceutical companies for the creation of diverse medications.
- Over the Counter (OTC) Drugs: In addition to prescription medications, the company offers a broad selection of over-the-counter drugs, enabling consumers to address common health problems promptly and effectively without the need for a prescription.
- Contract Manufacturing Services: Daito Pharmaceutical extends its expertise to offer contract manufacturing services, which encompass a range of capabilities from formulating products and handling high-potent drugs to providing packaging solutions. This service is tailored to meet the needs of other businesses within the pharmaceutical industry, leveraging Daito's state-of-the-art facilities and extensive experience.
